Focuses on the oversight strategies used to accelerate the recruitment of participants in clinical trials. Pressures on industry-sponsored clinical research according to a report by the U.S. Office of the Inspector General; Use of Web sites in recruiting participants; Information concerning clinical trials that should be given to participants.